摘要
代谢综合征(MetS)是一组以肥胖、高血糖、血脂异常以及高血压等聚集发病,严重影响机体健康的临床症候群。而尿微量白蛋白(MAU)作为一种肾功能指标,与代谢综合征存在一定的关系,并对代谢综合征疾病进展有一定预测性。本文综述既往研究中关于MAU与MetS各组分及其相关疾病之间的关系,并阐述MAU与MetS不良预后,即肾脏损伤以及心血管疾病的关系,论证MAU在MetS早期监测的意义。
Metabolic syndrome is a group of clinical symptoms,such as overweight and obesity,high blood sugar or hyperglycemia,a high triglyceride level,and high blood pressure,which seriously affect body health.As an indicator of renal function,microalbuminuria has a certain relationship with metabolic syndrome and could predict the progression of metabolic syndrome.In this review,we reviewed the previous studies on the relationship between microalbuminuria and the components of metabolic syndrome and their related diseases,and elaborated the relationship between microalbuminuria and the adverse prognosis of metabolic syndrome,namely kidney injury and cardiovascular disease,and demonstrated the significance of microalbuminuria in the early monitoring of metabolic syndrome.
作者
魏宇辰
刘峰
李强
杨兴华
WEI Yuchen;LIU Feng;LI Qiang;YANG Xinghua(School of Public Health,Capital Medical University,Beijing Municipal Key Laboratory of Clinical Epidemiology,Beijing 100069,China;Beijing Physical Examination Center,Beijing 100050,China)
出处
《健康体检与管理》
2022年第1期61-68,共8页
Journal of Health Examination and Management
基金
北京市自然科学基金项目(7202010)
国家重点研发计划主动健康和老龄化科技应对“健康体检大数据云平台构建”项目(2020YFC2003404)。
